Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGA | O60502 | 1/20 | 0.38 |
| ▸ | FGF1 | P05230 | 1/20 | 0.32 |
| ▸ | FBP1 | P09467 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15907822 | 0.85 | OGA (0.36) | OGAFGF1FBP1 | |
| SCHEMBL12017368 | 0.83 | FBP1 (0.37) | OGAFBP1 | |
| SCHEMBL15281693 | 0.83 | FGF1 (0.41) | OGAFGF1 | |
| SCHEMBL15095487 | 0.81 | LGALS3 (0.38) | — | |
| SCHEMBL24323044 | 0.81 | OGA (0.40) | OGAFGF1FBP1 | |
| SCHEMBL13301156 | 0.81 | OGA (0.40) | OGAFGF1FBP1 | |
| SCHEMBL12899827 | 0.81 | OGA (0.40) | OGAFGF1FBP1 | |
| SCHEMBL15887420 | 0.81 | OGA (0.40) | OGAFGF1FBP1 | |
| SCHEMBL12928783 | 0.81 | OGA (0.40) | OGAFGF1FBP1 | |
| SCHEMBL12899799 | 0.81 | OGA (0.40) | OGAFGF1FBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9035018-B2 | Furan-based curable compound derived from biomass, solvent-free curable composition, and method for preparing same | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2015-05-19 | — | — | US | disclosed |
| US-20120220742-A1 | Furan-Based Curable Compound Derived from Biomass, Solvent-Free Curable Composition, and Method for Preparing Same | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2012-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120220742-A1 | Furan-Based Curable Compound Derived from Biomass, Solvent-Free Curable Composition, and Method for Preparing Same | FASN, DCXR, CBR3 | OGA 340/4885FGF1 1509/4885FBP1 63/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.